IL157004A0 - Novel mixtures of microbial enzymes - Google Patents
Novel mixtures of microbial enzymesInfo
- Publication number
- IL157004A0 IL157004A0 IL15700402A IL15700402A IL157004A0 IL 157004 A0 IL157004 A0 IL 157004A0 IL 15700402 A IL15700402 A IL 15700402A IL 15700402 A IL15700402 A IL 15700402A IL 157004 A0 IL157004 A0 IL 157004A0
- Authority
- IL
- Israel
- Prior art keywords
- microbial enzymes
- novel mixtures
- mixtures
- novel
- microbial
- Prior art date
Links
- 102000004190 Enzymes Human genes 0.000 title 1
- 108090000790 Enzymes Proteins 0.000 title 1
- 230000000813 microbial effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10102495 | 2001-01-19 | ||
DE10144711A DE10144711A1 (de) | 2001-01-19 | 2001-09-11 | Neue Gemische mikrobieller Enzyme |
PCT/EP2002/000374 WO2002060474A2 (de) | 2001-01-19 | 2002-01-16 | Gemische von enzymen aus pilzen und deren verwendung zur behandlung der maldigestion |
Publications (1)
Publication Number | Publication Date |
---|---|
IL157004A0 true IL157004A0 (en) | 2004-02-08 |
Family
ID=26008287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15700402A IL157004A0 (en) | 2001-01-19 | 2002-01-16 | Novel mixtures of microbial enzymes |
Country Status (17)
Country | Link |
---|---|
US (1) | US20040057944A1 (cs) |
EP (1) | EP1381386A2 (cs) |
JP (1) | JP2004524838A (cs) |
CN (1) | CN1236817C (cs) |
AR (1) | AR032392A1 (cs) |
BR (1) | BR0206521A (cs) |
CA (1) | CA2434808A1 (cs) |
CZ (1) | CZ20031900A3 (cs) |
HU (1) | HUP0500560A3 (cs) |
IL (1) | IL157004A0 (cs) |
MX (1) | MXPA03005960A (cs) |
NO (1) | NO20033261D0 (cs) |
NZ (1) | NZ527148A (cs) |
PL (1) | PL362646A1 (cs) |
RU (1) | RU2003124078A (cs) |
SK (1) | SK9292003A3 (cs) |
WO (1) | WO2002060474A2 (cs) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6632429B1 (en) * | 1999-12-17 | 2003-10-14 | Joan M. Fallon | Methods for treating pervasive development disorders |
US20010046493A1 (en) * | 2000-02-24 | 2001-11-29 | Alex Margolin | Lipase-containing composition and methods of use thereof |
US20070053895A1 (en) * | 2000-08-14 | 2007-03-08 | Fallon Joan M | Method of treating and diagnosing parkinsons disease and related dysautonomic disorders |
IT1319655B1 (it) | 2000-11-15 | 2003-10-23 | Eurand Int | Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione. |
US8030002B2 (en) | 2000-11-16 | 2011-10-04 | Curemark Llc | Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions |
US8100844B2 (en) * | 2002-04-25 | 2012-01-24 | Ultraflex Systems, Inc. | Ambulating ankle and knee joints with bidirectional dampening and assistance using elastomeric restraint |
KR20060127857A (ko) * | 2003-10-29 | 2006-12-13 | 알투스 파마슈티컬스 인코포레이티드 | 혈장 콜레시스토키닌(cck) 농도 조절 및 통증 치료를위한 비-췌장 프로테아제 |
AU2005227090B2 (en) | 2004-03-22 | 2010-12-09 | Abbott Laboratories Gmbh | Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants |
RU2389504C2 (ru) * | 2004-05-24 | 2010-05-20 | Новозимс А/С | Ферменты для фармацевтического применения |
US20060198838A1 (en) * | 2004-09-28 | 2006-09-07 | Fallon Joan M | Combination enzyme for cystic fibrosis |
UA91521C2 (ru) * | 2004-10-14 | 2010-08-10 | Элтус Фармасьютикалз Инк. | Композиции, содержащие липазу, протеазу и амилазу, предназначенные для лечения недостаточности поджелудочной железы |
BRPI0611932A2 (pt) * | 2005-06-24 | 2011-01-04 | Novozymes As | amilase, uso da mesma, composição farmacêutica, e, método para o tratamento de uma doença |
BRPI0611936A2 (pt) * | 2005-06-24 | 2011-02-22 | Solvay Pharm Gmbh | protease, uso de uma protease, composição farmacêutica, e, método para o tratamento de doença |
CN101208429A (zh) * | 2005-06-24 | 2008-06-25 | 诺维信公司 | 用于药物用途的脂肪酶 |
US20070148151A1 (en) | 2005-07-29 | 2007-06-28 | Martin Frink | Processes for the manufacture and use of pancreatin |
US11266607B2 (en) | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
US9198871B2 (en) | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
EP1931317B1 (en) * | 2005-08-15 | 2008-12-24 | Solvay Pharmaceuticals GmbH | Pancreatin micropellets suitable for enteric coating |
US20080058282A1 (en) | 2005-08-30 | 2008-03-06 | Fallon Joan M | Use of lactulose in the treatment of autism |
US20070116695A1 (en) * | 2005-09-21 | 2007-05-24 | Fallon Joan M | Pharmaceutical preparations for attention deficit disorder, attention deficit hyperactivity disorder and other associated disorders |
US20100196344A1 (en) * | 2005-10-14 | 2010-08-05 | Cystic Fibrosis Foundation Therapeutics, Inc. | Compositions and methods for treating pancreatic insufficiency |
US8071089B2 (en) * | 2005-11-01 | 2011-12-06 | Bio-Cat, Inc. | Composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrosis as well as people suffering from pancreatic lipase insufficiency |
US10072256B2 (en) | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
US20080081035A1 (en) * | 2006-10-03 | 2008-04-03 | National Enzyme Company | Therapeutic protease compositions |
JP2010510310A (ja) | 2006-11-22 | 2010-04-02 | スタンダード バイオロジックス インコーポレイテッド | コウジカビプロテアーゼを使用する処置の方法 |
US8273348B2 (en) | 2006-12-21 | 2012-09-25 | Novozymes A/S | Lipase variants for pharmaceutical use |
US20080199448A1 (en) * | 2007-02-16 | 2008-08-21 | Ross Mairi R | Enzyme composition for improving food digestion |
ES2674681T3 (es) | 2007-02-20 | 2018-07-03 | Allergan Pharmaceuticals International Limited | Composiciones estables de enzimas digestivas |
US20090068174A1 (en) * | 2007-09-12 | 2009-03-12 | Kansas University Medical Center Research Institute, Inc. | Therapeutic alkaline protease compositions and use in facilitating the transport of agents across the gastrointestinal mucosal lining |
US20090130063A1 (en) * | 2007-11-15 | 2009-05-21 | Solvay Pharmaceuticals Gmbh | Process for separating and determining the viral load in a pancreatin sample |
AU2008333313A1 (en) | 2007-12-04 | 2009-06-11 | Novozymes A/S | Protease variants for pharmaceutical use |
US20110008423A1 (en) * | 2008-01-03 | 2011-01-13 | Abbott Products Gmbh | Pharmaceutical compositions comprising granules of purified microbial lipase and methods for preventing or treating digestive disorders |
US10087493B2 (en) | 2008-03-07 | 2018-10-02 | Aptalis Pharma Canada Ulc | Method for detecting infectious parvovirus in pharmaceutical preparations |
US8658163B2 (en) | 2008-03-13 | 2014-02-25 | Curemark Llc | Compositions and use thereof for treating symptoms of preeclampsia |
US8084025B2 (en) | 2008-04-18 | 2011-12-27 | Curemark Llc | Method for the treatment of the symptoms of drug and alcohol addiction |
US9320780B2 (en) | 2008-06-26 | 2016-04-26 | Curemark Llc | Methods and compositions for the treatment of symptoms of Williams Syndrome |
US20090324730A1 (en) * | 2008-06-26 | 2009-12-31 | Fallon Joan M | Methods and compositions for the treatment of symptoms of complex regional pain syndrome |
WO2010002972A1 (en) * | 2008-07-01 | 2010-01-07 | Curemark, Llc | Methods and compositions for the treatment of symptoms of neurological and mental health disorders |
US10776453B2 (en) * | 2008-08-04 | 2020-09-15 | Galenagen, Llc | Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain |
WO2010037695A1 (en) * | 2008-09-30 | 2010-04-08 | Dsm Ip Assets B.V. | Enzyme composition and application thereof in the treatment of pancreatic insufficiency |
US20100092447A1 (en) | 2008-10-03 | 2010-04-15 | Fallon Joan M | Methods and compositions for the treatment of symptoms of prion diseases |
AU2015252099B2 (en) * | 2009-01-06 | 2017-08-10 | Galenagen, Llc | Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces |
NZ593831A (en) | 2009-01-06 | 2013-09-27 | Curelon Llc | Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces |
ES2727746T3 (es) | 2009-01-06 | 2019-10-18 | Galenagen Llc | Composiciones orales para el tratamiento o la prevención de infecciones por E. Coli |
US9056050B2 (en) * | 2009-04-13 | 2015-06-16 | Curemark Llc | Enzyme delivery systems and methods of preparation and use |
WO2011050135A1 (en) | 2009-10-21 | 2011-04-28 | Curemark Llc | Methods and compositions for the prevention and treatment of influenza |
MX2012010755A (es) * | 2010-03-19 | 2013-03-08 | Aptalis Pharma Canada Inc | Composiciones farmaceuticas de enzimas gastro-resistentes. |
RS53587B1 (en) | 2010-10-01 | 2015-02-27 | Aptalis Pharma Limited | ENTERICALLY LOWER PANCRELIPASE FORMULATIONS |
CA2822637C (en) | 2010-12-22 | 2020-06-30 | Novozymes North America, Inc. | Processes for producing fermentation products |
WO2012145651A2 (en) | 2011-04-21 | 2012-10-26 | Curemark, Llc | Compounds for the treatment of neuropsychiatric disorders |
ES2734221T3 (es) | 2011-08-08 | 2019-12-04 | Allergan Pharmaceuticals Int Ltd | Método para la prueba de disolución de composiciones sólidas que contienen enzimas digestivas |
US20140315243A1 (en) * | 2011-12-02 | 2014-10-23 | Novozymes A/S | Processes for producing fermentation products |
US10350278B2 (en) | 2012-05-30 | 2019-07-16 | Curemark, Llc | Methods of treating Celiac disease |
ES2681343T3 (es) | 2012-09-19 | 2018-09-12 | Grespo Ab | Composiciones para la mejora de la función cerebral |
CN105209062A (zh) | 2013-03-15 | 2015-12-30 | 阿普塔利斯制药有限公司 | 适于经肠施用的包含消化酶和营养物的组合物 |
US11939552B2 (en) | 2013-06-24 | 2024-03-26 | Novozymes A/S | Process of recovering oil |
WO2014209789A1 (en) | 2013-06-24 | 2014-12-31 | Novozymes A/S | Process of extracting oil from thin stillage |
AU2014304176A1 (en) * | 2013-07-22 | 2016-02-11 | Aptalis Pharma Ltd. | High potency pancreatin pharmaceutical compositions |
WO2015020943A2 (en) | 2013-08-09 | 2015-02-12 | Aptalis Pharma Ltd. | Digestive enzyme composition suitable for enteral administration |
MX2016000480A (es) | 2013-11-05 | 2016-10-21 | Allergan Pharmaceuticals Int Ltd | Composiciones farmaceuticas de pancreatina de alta potencia. |
JP2017519490A (ja) | 2014-06-19 | 2017-07-20 | アプタリス ファルマ リミテッド | 膵臓抽出物からのウイルス汚染の除去方法 |
GB201501081D0 (en) | 2015-01-22 | 2015-03-11 | Cilian Ag | Use of enzymes with a wide pH activity range as medicaments for promoting digestion |
WO2016126970A1 (en) | 2015-02-04 | 2016-08-11 | Abbvie Inc. | Pharmaceutical compositions and methods of use thereof to treat pancreatic enzyme insufficiency |
US20200291375A1 (en) * | 2017-09-24 | 2020-09-17 | Bio-Cat, Inc. | Fungal protease mixtures and uses thereof |
FR3079146B1 (fr) | 2018-03-23 | 2020-04-17 | Karim Ioualalen | Formulation gastroprotectrice de complexes d’enzymes permettant de restaurer la fonction digestive. |
FR3111559A1 (fr) * | 2020-06-18 | 2021-12-24 | Azurrx Biopharma, Inc. | Formulations non porcines et leurs procédés |
US11541009B2 (en) | 2020-09-10 | 2023-01-03 | Curemark, Llc | Methods of prophylaxis of coronavirus infection and treatment of coronaviruses |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1084431A (en) * | 1964-05-06 | 1967-09-20 | Analyses Et De Rech S Biolog M | Improvements in and relating to lipases |
DE2638088C3 (de) * | 1976-08-24 | 1979-06-21 | Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt | Verwendung von SuBmolkenpulver |
JP3152958B2 (ja) * | 1991-06-14 | 2001-04-03 | 天野エンザイム株式会社 | 微生物起源リパーゼの安定化組成物及び安定化法 |
DE4332985A1 (de) * | 1993-09-28 | 1995-03-30 | Konrad Peter Maria Dr Sommer | Arzneimittel zur Behandlung der Dysfunktion des exokrinen Pankreas |
US5750104A (en) * | 1996-05-29 | 1998-05-12 | Digestive Care Inc. | High buffer-containing enteric coating digestive enzyme bile acid compositions and method of treating digestive disorders therewith |
US6013680A (en) * | 1997-10-21 | 2000-01-11 | Amano Pharmaceutical Co., Ltd. | Digestive enzyme-containing medicament |
-
2002
- 2002-01-10 AR ARP020100070A patent/AR032392A1/es not_active Application Discontinuation
- 2002-01-16 WO PCT/EP2002/000374 patent/WO2002060474A2/de not_active Application Discontinuation
- 2002-01-16 SK SK929-2003A patent/SK9292003A3/sk unknown
- 2002-01-16 PL PL02362646A patent/PL362646A1/xx not_active Application Discontinuation
- 2002-01-16 CZ CZ20031900A patent/CZ20031900A3/cs unknown
- 2002-01-16 CN CNB028038894A patent/CN1236817C/zh not_active Expired - Fee Related
- 2002-01-16 IL IL15700402A patent/IL157004A0/xx unknown
- 2002-01-16 CA CA002434808A patent/CA2434808A1/en not_active Abandoned
- 2002-01-16 EP EP02716661A patent/EP1381386A2/de not_active Withdrawn
- 2002-01-16 BR BR0206521-5A patent/BR0206521A/pt not_active IP Right Cessation
- 2002-01-16 MX MXPA03005960A patent/MXPA03005960A/es unknown
- 2002-01-16 JP JP2002560665A patent/JP2004524838A/ja not_active Withdrawn
- 2002-01-16 RU RU2003124078/15A patent/RU2003124078A/ru not_active Application Discontinuation
- 2002-01-16 NZ NZ527148A patent/NZ527148A/en unknown
- 2002-01-16 HU HU0500560A patent/HUP0500560A3/hu unknown
-
2003
- 2003-07-17 US US10/620,759 patent/US20040057944A1/en not_active Abandoned
- 2003-07-18 NO NO20033261A patent/NO20033261D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2003124078A (ru) | 2005-01-27 |
CN1236817C (zh) | 2006-01-18 |
HUP0500560A3 (en) | 2006-06-28 |
WO2002060474A2 (de) | 2002-08-08 |
CN1487837A (zh) | 2004-04-07 |
JP2004524838A (ja) | 2004-08-19 |
NZ527148A (en) | 2005-01-28 |
SK9292003A3 (en) | 2003-12-02 |
MXPA03005960A (es) | 2003-09-05 |
NO20033261L (no) | 2003-07-18 |
BR0206521A (pt) | 2004-02-17 |
HUP0500560A2 (hu) | 2005-09-28 |
US20040057944A1 (en) | 2004-03-25 |
WO2002060474A3 (de) | 2003-10-30 |
PL362646A1 (en) | 2004-11-02 |
AR032392A1 (es) | 2003-11-05 |
NO20033261D0 (no) | 2003-07-18 |
EP1381386A2 (de) | 2004-01-21 |
CZ20031900A3 (cs) | 2003-10-15 |
CA2434808A1 (en) | 2002-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL157004A0 (en) | Novel mixtures of microbial enzymes | |
AU2002357860A8 (en) | Enzymes | |
GB0130789D0 (en) | Application of spores | |
AU2001271427A1 (en) | Novel proteases | |
GB0017387D0 (en) | Novel enzyme | |
AU2002242633A1 (en) | Fermentation process including the use of enzymes | |
IL157426A0 (en) | Peg-conjugates of hgf-nk4 | |
GB0011186D0 (en) | Modification of bacteria | |
AU2002347778A1 (en) | Enzymes | |
AU2001285693A1 (en) | Bio-reactor | |
AU2002358179A1 (en) | New rennets | |
AU2002356615A1 (en) | Novel utilization of cyclopentabenzofurans | |
ZA200304986B (en) | Novel mixtures of microbial enzymes. | |
AU2002257273A1 (en) | Enzymes | |
AUPS282802A0 (en) | Novel enzymes | |
AU2002355993A1 (en) | Resuscitation of not immediately culturable bacteria | |
AUPR482001A0 (en) | Metal-handling enzymes | |
GB0121840D0 (en) | Modified enzyme | |
GB0102946D0 (en) | Enzyme | |
GB0128943D0 (en) | Bacterial enzyme inhibitors | |
HU0104370D0 (en) | Honeyed schnaps of oerseg | |
SI1457551T1 (sl) | Novi mikroorganizem | |
GB0124575D0 (en) | Enzyme | |
GB0110044D0 (en) | Enzyme | |
AU2002303756A1 (en) | Novel methods of enzyme purification |